MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 7031-7040 Newer>
The Motley Fool
December 30, 2010
Brian Orelli
This NICE Deal Could Foreshadow 2011 Value-based pricing is coming. The only way to encourage lower drug costs is to get the end user to pay the cost directly. mark for My Articles 836 similar articles
The Motley Fool
December 30, 2010
Brian Orelli
2011 Drugmaker M&A Targets What Big Pharma M&A deals will 2011 hold? Most likely, more small deals, and perhaps Sanofi will finally offer a reasonable price for Genzyme. Let's take a look at some of the companies that might be walking down the aisle next year. mark for My Articles 843 similar articles
BusinessWeek
December 29, 2010
Kelley & Cortez
AstraZeneca's Risky Bet on Drug Discovery Instead of acquisitions and diversification, AstraZeneca is determined to find new pills in its own labs. mark for My Articles 913 similar articles
BusinessWeek
December 29, 2010
David M. Levitt
Cleveland Wants to Be a Health-Care Hub The city tries to rebrand itself by building a medical mart and convention center in hopes of attracting well-paying industry jobs to the region. mark for My Articles 11 similar articles
BusinessWeek
December 29, 2010
Greg Stohr
The Court Case Haunting Health Care Legal challenges to health reform will use a 1942 precedent, when the Supreme Court broadened Congress' right to regulate interstate commerce. mark for My Articles 32 similar articles
The Motley Fool
December 29, 2010
Seth Jayson
Why Varian Medical Systems' Earnings Are Outstanding With 16.6% of operating cash flow coming from questionable sources, Varian Medical Systems investors should take a closer look at the underlying numbers. mark for My Articles 662 similar articles
The Motley Fool
December 29, 2010
Seth Jayson
Steris Passes This Key Test For the last fully reported fiscal quarter, Steris' year-over-year revenue shrank 0.6%, and its AR dropped 5.9%. That looks OK. mark for My Articles 259 similar articles
The Motley Fool
December 28, 2010
Brian Orelli
Double-Digit Increase! Haven't We Learned Anything? MannKind's investors need a history lesson. mark for My Articles 643 similar articles
The Motley Fool
December 28, 2010
Brian Orelli
No Guts, No Glory For better or worse, Elan gains full control of Alzheimer's drug ELND005. mark for My Articles 261 similar articles
The Motley Fool
December 28, 2010
Seth Jayson
Does This Mean SXC Health Solutions Will Burn You? I would not be surprised if there were trouble ahead. mark for My Articles 260 similar articles
<Older 7031-7040 Newer>    Return to current articles.